Impact on survival of different treatmen
β
Kathrin Nachtkamp; Andrea KΓΌndgen; Corinna Strupp; Aristoteles Giagounidis; Guid
π
Article
π
2009
π
Elsevier Science
π
English
β 568 KB
Therapies for myelodysplastic syndromes (MDS) often achieve hematological responses but their impact on overall survival has generally not been evaluated. The Duesseldorf MDS Registry allowed us to perform matched-pair analyses to assess a possible survival benefit of treatment with thalidomide, val